Drugs Made In America Acquisition II

DMIIU · NASDAQ

$10.26+$0.0293 (+0.29%)TodayMarket closed · Nov 6, 4:00 PM ET

No price history for this range.

About DMIIU

Drugs Made In America Acquisition II Corp. operates as a blank check company. The company is headquartered in New York City, New York. The company went IPO on 2025-09-25. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. While the Company may pursue a business combination target in any business, industry or geographical location, it intends to focus its search for businesses in the pharmaceutical industry. The firm has neither engaged in any operations nor generated any revenue to date.

Employees: 0
Headquarters: New York City, New York
Listed: Sep 25, 2025
Sector: N/A
Industry: N/A

DMIIU key statistics

Market cap: 650.38M
Price-earnings ratio: 0.00
Dividend yield: —
Average volume: 460
Volume: 392
Open price: $10.23
High today: $10.26
Low today: $10.26
52 Week high: $10.80
52 Week low: $9.97

Drugs Made In America Acquisition II (DMIIU) at a glance

As of Nov 6, 2026, Drugs Made In America Acquisition II (DMIIU) shares are priced at $10.26, giving the company a market cap of 650.38M and a price-to-earnings ratio of 0.00.

Volume so far is 392 shares, in line with the average of 460 shares a day.

Over the past year Drugs Made In America Acquisition II has ranged from $9.97 to $10.80, and now sits 35% of the way up that range.

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.